Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FALFT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,549
Award facts
- Contract value 100% obligated
- $11,549.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $11,549.31 delivery order to Amerisourcebergen Drug Corp on March 12, 2026, for Dupixent 300 mg/2 mL syringes under a firm fixed-price arrangement with ultimate completion on March 13, 2026.
Place of performance is Conshohocken, PA. The order carries no set-aside designation.
Quick answers
Who was awarded contract SPE2DR26FALFT?
SPE2DR26FALFT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 12, 2026.
How much is contract SPE2DR26FALFT worth?
The government has obligated $11,549 on SPE2DR26FALFT.
Is contract SPE2DR26FALFT an order under another contract?
Yes. SPE2DR26FALFT is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FALFT competed?
The extent of competition for SPE2DR26FALFT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award